The pH-Responsive Liposomes—The Effect of PEGylation on Release Kinetics and Cellular Uptake in Glioblastoma Cells

Nanomedicine has been, to a certain degree, a success story in the development of superior anticancer therapies. However, there are tumors that remain a huge challenge for nanoformulations, for instance, brain tumors such as glioblastoma, the most common and aggressive brain tumor. To utilize the fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rustad, Eirik A. L., von Hofsten, Susannah, Kumar, Robin, Lænsman, Eirik A., Berge, Gerd, Škalko-Basnet, Nataša
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227832/
https://www.ncbi.nlm.nih.gov/pubmed/35745698
http://dx.doi.org/10.3390/pharmaceutics14061125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227832/
https://www.ncbi.nlm.nih.gov/pubmed/35745698
http://dx.doi.org/10.3390/pharmaceutics14061125

Ejemplares similares